EW DELHI: Drug major Lupin said it has launched the generic version of Allergan Inc's Zymaxid Ophthalmic Solution in the US market with 180 days of marketing exclusivity.
Lupin Launches Generic Ophthalmic Solution in US Market
- Details
EW DELHI: Drug major Lupin said it has launched the generic version of Allergan Inc's Zymaxid Ophthalmic Solution in the US market with 180 days of marketing exclusivity.